Cystic Fibrosis Gene Therapy – Not Low-hanging Fruit
European Respiratory & Pulmonary Diseases · 2016
DOI: 10.17925/erpd.2016.02.02.48 ↗Abstract
The last 25 years have shown that it has been comparatively slow and difficult to develop cystic fibrosis (CF) gene therapy; the lung is a complex target organ. However, research has steadily progressed and recently it was shown that non-viral gene therapy can stabilise CF lung disease. These data, in addition to the development of potent lentiviral vectors, have renewed interest in CF gene therapy within academia and industry.
EUVIMED